Back to Search
Start Over
Performance-based risk-sharing agreements in renal care: current experience and future prospects
- Source :
- Expert Review of Pharmacoeconomics & Outcomes Research. 21:197-210
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- INTRODUCTION: Performance-based risk-sharing agreements (PBRSAs), between payers, health care providers, and technology manufacturers can be useful when there is uncertainty about the (cost-) effectiveness of a new technology or service. However, they can be challenging to design and implement. AREAS COVERED: A total of 18 performance-based agreements were identified through a literature review. All but two of the agreements identified were pay-for-performance schemes, agreed between providers and payers at the national level. No examples were found of agreements between health care providers and manufacturers at the local level. The potential for these local agreements was illustrated by hypothetical case studies of water quality management and an integrated chronic kidney disease program. EXPERT OPINION: Performance-based risk-sharing agreements can work to the advantage of patients, health care providers, payers, and technology manufacturers, particularly if they facilitate the introduction of technologies or systems of care that might not have been introduced otherwise. However, the design, conduct, and implementation of PBRSAs in renal care pose a number of challenges. Efforts should be made to overcome these challenges so that more renal care patients can benefit from technological advances and new models of care.
- Subjects :
- PERFORMANCE ASSESSMENT
Cost-Benefit Analysis
COST-EFFECTIVENESS ANALYSIS
Renal care
REIMBURSEMENT
03 medical and health sciences
0302 clinical medicine
SDG 3 - Good Health and Well-being
Water Quality
Health care
Risk sharing
Humans
Pharmacology (medical)
Operations management
RISK SHARING
030212 general & internal medicine
Renal Insufficiency, Chronic
Reimbursement, Incentive
Reimbursement
HEALTH TECHNOLOGY ASSESSMENT
business.industry
030503 health policy & services
Health Policy
Uncertainty
General Medicine
Cost-effectiveness analysis
Risk Sharing, Financial
HEALTH TECHNOLOGY ASSESSMENT, COST-EFFECTIVENESS ANALYSIS, PERFORMANCE ASSESSMENT, REIMBURSEMENT, RISK SHARING
0305 other medical science
business
Delivery of Health Care
Subjects
Details
- ISSN :
- 17448379 and 14737167
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Expert Review of Pharmacoeconomics & Outcomes Research
- Accession number :
- edsair.doi.dedup.....ffd05451cf0f266cf0aebce2ccb39080
- Full Text :
- https://doi.org/10.1080/14737167.2021.1876566